2026
H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ
Anurag Relan, Chief Medical Officer and Michael Levitan, VP Investor Relations and Capital Markets will participate in a Fireside Chat on Tuesday, May 19 at 11:30 am EDT/17:30 CEST.
Annual General Meeting (AGM) 2026
Pharming 2026 Annual General Meeting of Shareholders (AGM) will be held on Thursday May 28, 2026. The Notice to Convene, Explanatory Notes, Proxy and other meeting documents for the AGM can be found on the page Shareholder Meetings.
Read morePharming 2Q/1H 2026 Financial Results
Pharming to report 2Q/1H 2026 financial results on July 30, 2026, at 07:00 CET. You can find other results on our Financial Documents page.
Pharming 3Q 2026 Financial Results
Pharming to report 3Q 2026 financial results on November 5, 2026, at 07:00 CET. You can find other results on our Financial Documents page.